This article presents a comprehensive review and analysis of global standards in vaccine management, with a specific focus on the context of vaccine manufacturing in Bangladesh. By examining the current scenario of vaccine production in Bangladesh, this study aims to identify strengths, challenges, and potential areas for improvement in order to enhance the country's vaccine manufacturing capabilities. The analysis of global standards highlights the importance of quality control measures, supply chain management, storage and distribution practices, cold chain systems, and post-marketing surveillance. The findings from this study contribute to the understanding of vaccine management practices and provide insights for optimizing vaccine manufacturing in Bangladesh.

Vaccine management, global standards, vaccine manufacturing

Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. The Pediatric infectious disease journal. 2000 Mar 1;19(3):187-95.

Graham JE, Borda-Rodriguez A, Huzair F, Zinck E. Capacity for a global vaccine safety system: the perspective of national regulatory authorities. Vaccine. 2012 Jul 13;30(33):4953-9.

Smith PJ, Battaglia MP, Huggins VJ, Hoaglin DC, Rodén AS, Khare M, Ezzati-Rice TM, Wright RA. Overview of the sampling design and statistical methods used in the National Immunization Survey22. American Journal of Preventive Medicine. 2001 May 1;20(4):17-24.

Habib MA, Alam MZ. Business analysis of pharmaceutical firms in Bangladesh: problems and prospects. Journal of Business and Technology (Dhaka). 2011;6(1):61-77.

World Health Organization. Global Vaccine Action Plan 2011-2020. Global Vaccine Action Plan 2011-2020.. 2013.

Marshall V, Baylor NW. Food and Drug Administration regulation and evaluation of vaccines. Pediatrics. 2011 Apr 18:peds-2010.

Zaffran M, Vandelaer J, Kristensen D, Melgaard B, Yadav P, Antwi- Agyei KO, Lasher H. The imperative for stronger vaccine supply and logistics systems. Vaccine. 2013 Apr 18;31:B73-80.

Levinson DR, General I. Vaccines for children program: vulnerabilities in vaccine management. Department of Health and Human Services: Office of Inspector General. 2012 Jun.

Nossal GJ. Vaccines and future global health needs. Philosophical Transactions of the Royal Society of London B: Biological Sciences. 2011 Oct 12;366(1579):2833-40.

Rappuoli R, Mandl CW, Black S, De Gregorio E. Vaccines for the twenty-first century society. Nature Reviews Immunology. 2011 Dec;11(12):865.